Health informatics company Alcidion Group (ASX: ALC) has launched an Australian-first mobile Electronic Medical Record (EMR) application which gives doctors real-time access to caseloads, critical issues and patient records on the go.
The new generation Miya MEMRe app is the first locally-developed mobile solution to offer full access to EMR data, enabling the quick and efficient review of patient data for enhanced decision making.
Built on the Apple iOS platform to provide advanced security and a familiar interface, it is the first EMR solution in Australia to employ FHIR (Fast Healthcare Interoperability Resources) clinical events and the first of its kind to be source system agnostic.
Miya MEMRe uses artificial intelligence to refine critical notifications and action lists, and is designed to access the vast amount of information available in an organisation’s EMR and medical systems.
It is currently being trialled in Australian health services, interacting with local clinical systems and providing clinicians in high-intensity areas such as emergency departments with critical test results and risk indicators in real-time, via mobile devices.
Alcidion chief medical officer Dr Malcolm Pradhan said Miya MEMRe was developed to improve the delivery and safety of healthcare.
“By giving doctors access to the information they need to make decisions and take action, we help them deliver the best possible care and outcomes for their patients,” he said.
“Our technology makes life on the floor simpler, improves efficiency, and can even deliver new insights to help health organisations evolve and innovate.”
He said the app will distill all data and present it in an “intuitive and focused user interface” which aligns to clinical workflow.
It will inform doctors of important issues, identify problem areas and trends, and give access to data needed to deliver personalised and precise care.
Using the Miya MEMRe app, doctors can instantly see their caseload – admissions, discharges, patients in ED, consult requests and reviews – and prioritise their time.
Sophisticated detection rules issue timely notifications for the review of critical events such as lab results, vital signs and patient deterioration.
Notifications include patient context, current medications and problem lists so doctors can understand the clinical context and take the best course of action.
Dr Pradhan said the app has been designed to promote best practice compliance by reducing the cognitive load on doctors, minimising variation, and lessening delays which could lead to patient harm.
At midday, shares in Alcidion were up 5.26% to $0.20.